Botanical compounds: Effects on major eye diseases

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Huynh, Tuan Phat ^a,b,c   Mann, Shivani N ^a,b   Mandal, Nawajes A ^a,b,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATECHIN; CROCIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GINKGO BILOBA EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RG 3; HERBACEOUS AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLANT EXTRACT; QUERCETIN; RESVERATROL; RETINOL PALMITATE; SAFFRON; TERPENOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

APOPTOSIS; BLINDNESS; BLURRED VISION; CATARACT; CATARACTOGENESIS; CYTOTOXICITY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; ELECTRORETINOGRAM; ENDOPLASMIC RETICULUM STRESS; EYE CARE; EYE DISEASE; EYE INJURY; GENETIC PREDISPOSITION; GINSENG; GLAUCOMA; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; LOW TENSION GLAUCOMA; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; SALVIA MILTIORRHIZA; SMOKING; THROMBOCYTE AGGREGATION; UNSPECIFIED SIDE EFFECT; VISION; VITREORETINOPATHY;

EID: 84880169524     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/549174     Document Type: Review

References (129)

1. Cragg G. M., Newman D. J., Biodiversity: a continuing source of novel drug leads. Pure and Applied Chemistry 2005 77 1 7 24 2-s2.0-14644436385 10.1351/pac200577010007 (Pubitemid 40321875)
2. Dias D. A., Urban S., Roessner U., A historical overview of natural products in drug discovery. Metabolites 2012 2 2 303 336 10.3390/metabo2020303
3. Gurib-Fakim A., Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine 2006 27 1 1 93 2-s2.0-29044445562 10.1016/j.mam.2005.07.008 (Pubitemid 41790645)
4. Quigley H., Broman A. T., The number of people with glaucoma worldwide in 2010 and 2020. The British Journal of Ophthalmology 2006 90 3 262 267 2-s2.0-33644655886 10.1136/bjo.2005.081224 (Pubitemid 43325451)
5. Klein R., Peto T., Bird A., Vannewkirk M. R., The epidemiology of age-related macular degeneration. The American Journal of Ophthalmology 2004 137 3 486 495 2-s2.0-1542297335 10.1016/j.ajo.2003.11.069 (Pubitemid 38328641)
6. Farnsworth N. R., Akerele O., Bingel A. S., Medicinal plants in therapy. Bulletin of the World Health Organization 1985 63 6 965 981 2-s2.0-0022191565 (Pubitemid 16055431)
7. Congdon N., Vingerling J. R., Klein B. E., West S., Friedman D. S., Kempen J., O'Colmain B., Wu S. Y., Taylor H. R., Eye Diseases Prevalence Research Group, Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Archives of Ophthalmology 2004 122 4 487 494 2-s2.0-1842425722 10.1001/archopht.122.4.487 (Pubitemid 38456283)
8. Kempen J. H., O'Colmain B. J., Leske M. C., Haffner S. M., Klein R., Moss S. E., Taylor H. R., Hamman R. F., West S. K., Wang J. J., Congdon N. G., Friedman D. S., The prevalence of diabetic retinopathy among adults in the United States. Archives of Ophthalmology 2004 122 4 552 563 2-s2.0-11144356305 10.1001/archopht.122.4.552 (Pubitemid 38456292)
9. Shen J. K., Dong A., Hackett S. F., Bell W. R., Green W. R., Campochiaro P. A., Oxidative damage in age-related macular degenration. Histology and Histopathology 2007 22 12 1301 1308 (Pubitemid 47470323)
10. Hollyfield J. G., Bonilha V. L., Rayborn M. E., Yang X., Shadrach K. G., Lu L., Ufret R. L., Salomon R. G., Perez V. L., Oxidative damage-induced inflammation initiates age-related macular degeneration. Nature Medicine 2008 14 2 194 198 2-s2.0-38949185692 10.1038/nm1709 (Pubitemid 351214555)
11. Donoso L. A., Kim D., Frost A., Callahan A., Hageman G., The role of inflammation in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 2006 51 2 137 152 2-s2.0-33144459399 10.1016/j.survophthal.2005. 12.001 (Pubitemid 43269939)
12. Age-Related Eye Disease Study Research Group, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, β carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology 2008 119 10 1417 1436
13. AREDS2 Research Group, Chew E. Y., Clemons T., SanGiovanni J. P., Danis R., Domalpally A., McBee W., Sperduto R., Ferris F. L., The age-related eye sisease study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophtalmology 2012 119 11 2282 2289 10.1016/j.ophtha.2012.05. 027
14. Anderson D. R., Tasman W., Jaeger E. A., The optic nerve in glaucoma. Duane's Ophthalmology 2009 Philadelphia, Pa, USA Lippincott Williams & Wilkins
15. Ritch R., Natural compounds: evidence for a protective role in eye disease. Canadian Journal of Ophthalmology 2007 42 3 425 438 2-s2.0-34250661782 10.3129/I07-044 (Pubitemid 46932038)
16. Mandelcorn E., Gupta N., Tasman W., Jaeger E. A., Lens-related glaucomas. Duane's Ophthalmology 2009 Philadelphia, Pa, USA Lippincott Williams & Wilkins
17. Yau J. W. Y., Rogers S. L., Kawasaki R., Lamoureux E. L., Kowalski J. W., Bek T., Chen S., Dekker J. M., Fletcher A., Grauslund J., Haffner S., Hamman R. F., Ikram M. K., Kayama T., Klein B. E. K., Klein R., Krishnaiah S., Mayurasakorn K., O'Hare J. P., Orchard T. J., Porta M., Rema M., Roy M. S., Sharma T., Shaw J., Taylor H., Tielsch J. M., Varma R., Wang J. J., Wang N., West S., Zu L., Yasuda M., Zhang X., Mitchell P., Wong T. Y., Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012 35 3 556 564 2-s2.0-84859030420 10.2337/dc11-1909
18. Fong D. S., Aiello L., Gardner T. W., King G. L., Blankenship G., Cavallerano J. D., Ferris F. L. III, Klein R., MPH and for the American Diabetes Association, Diabetic retinopathy. Diabetes Care 2003 26 1 S99 S102 2-s2.0-0037584742 (Pubitemid 36934460)
19. Sieving P. A., Caruso R. C., Yanoff M., Duker J. S., Retinitis pigmentosa and related disorders. Ophthalmology 2008 Maryland Heights, Mo, USA Mosby Elsevier
20. Radu R. A., Yuan Q., Hu J., Peng J. H., Lloyd M., Nusinowitz S., Bok D., Travis G. H., Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Investigative Ophthalmology and Visual Science 2008 49 9 3821 3829 2-s2.0-53149096200 10.1167/iovs.07-1470
21. Zigler J. S. Jr., Datiles M. B. III, Tasman W., Jaeger E. A., Pathogenesis of cataracts. Duane's Ophthalmology 2011 Philadelphia, Pa, USA Lippincott Williams & Wilkins
22. Brian G., Taylor H., Cataract blindness-challenges for the 21st century. Bulletin of the World Health Organization 2001 79 3 249 256 2-s2.0-0035088540 (Pubitemid 32246485)
23. Tilak J. C., Banerjee M., Mohan H., Devasagayam T. P. A., Antioxidant availability of turmeric in relation to its medicinal and culinary uses. Phytotherapy Research 2004 18 10 798 804 2-s2.0-9644303070 10.1002/ptr.1553 (Pubitemid 39577240)
24. Aggarwal B. B., Kumar A., Bharti A. C., Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research 2003 23 1 363 398 2-s2.0-0037236792 (Pubitemid 36361976)
25. Wang Y., Pan M., Cheng A., Lin L., Ho Y., Hsieh C., Lin J., Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of Pharmaceutical and Biomedical Analysis 1997 15 12 1867 1876 2-s2.0-0030839940 10.1016/S0731-7085(96)02024-9 (Pubitemid 27341993)
26. Goel A., Kunnumakkara A. B., Aggarwal B. B., Curcumin as "Curecumin": from kitchen to clinic. Biochemical Pharmacology 2008 75 4 787 809 2-s2.0-38749109673 10.1016/j.bcp.2007.08.016 (Pubitemid 351181424)
27. Abe Y., Hashimoto S., Horie T., Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacological Research 1999 39 1 41 47 2-s2.0-0032991568 10.1006/phrs.1998.0404 (Pubitemid 29101333)
28. Mandal M. N. A., Patlolla J. M. R., Zheng L., Agbaga M., Tran J. A., Wicker L., Kasus-Jacobi A., Elliott M. H., Rao C. V., Anderson R. E., Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radical Biology and Medicine 2009 46 5 672 679 2-s2.0-59249104565 10.1016/j.freeradbiomed.2008.12.006
29. Woo J. M., Shin D. Y., Lee S. J., Joe Y., Zheng M., Yim J. H., Callaway Z., Chung H. T., Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen. Molecular Vision 2012 18 901 908
30. Gupta S. K., Kumar B., Nag T. C., Agrawal S. S., Agrawal R., Agrawal P., Saxena R., Srivastava S., Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. Journal of Ocular Pharmacology and Therapeutics 2011 27 2 123 130 2-s2.0-79955008744 10.1089/jop.2010.0123
31. Suryanarayana P., Saraswat M., Mrudula T., Krishna T. P., Krishnaswamy K., Reddy G. B., Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Investigative Ophthalmology and Visual Science 2005 46 6 2092 2099 2-s2.0-22144432295 10.1167/iovs.04-1304
32. Raju T. N., Kumar C. S., Kanth V. R., Ramana B. V., Reddy P. U. M., Suryanarayana P., Reddy G. B., Cumulative antioxidant defense against oxidative challenge in galactose-induced cataractogenesis in Wistar rats. Indian Journal of Experimental Biology 2006 44 9 733 739 2-s2.0-33748577329 (Pubitemid 44369303)
33. Pandya U., Saini M. K., Jin G. F., Awasthi S., Godley B. F., Awasthi Y. C., Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicology Letters 2000 115 3 195 204 2-s2.0-0034608429 10.1016/S0378-4274(00)00191-0 (Pubitemid 30256177)
34. Manikandan R., Thiagarajan R., Beulaja S., Sudhandiran G., Arumugam M., Effect of curcumin on selenite-induced cataractogenesis in wistar rat pups. Current Eye Research 2010 35 2 122 129 2-s2.0-76749161371 10.3109/ 02713680903447884
35. Kumar P. A., Suryanarayana P., Reddy P. Y., Reddy G. B., Modulation of crystallin chaperone activity in diabetic rat lens by curcumin. Molecular Vision 2005 11 561 568 2-s2.0-26244442494 (Pubitemid 41410220)
36. Goodpasture C. E., Arrighi F. E., Effect of food seasoning on the cell cycle and chromosome morphology of mammalian cells in vitro with special reference to turmeric. Food and Cosmetics Toxicology 1976 14 1 9 14 2-s2.0-0017105016
37. Giri A. K., Das S. K., Talukder G., Sharma A., Sister chromatid exchange and chromosome aberrations induced by curcumin and tartrazine on mammalian cells in vivo. Cytobios 1990 62 249 111 117 2-s2.0-0025113795 (Pubitemid 20283442)
38. Ahsan H., Hadi S. M., Strand scission in DNA induced by curcumin in the presence of Cu(II). Cancer Letters 1998 124 1 23 30 2-s2.0-0032512698 10.1016/S0304-3835(97)00442-4 (Pubitemid 28073804)
39. Sakano K., Kawanishi S., Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes. Archives of Biochemistry and Biophysics 2002 405 2 223 230 2-s2.0-0036401602 10.1016/S0003-9861(02)00302-8 (Pubitemid 35191736)
40. Nair J., Strand S., Frank N., Knauft J., Wesch H., Galle P. R., Bartsch H., Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in long-evans cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 2005 26 7 1307 1315 2-s2.0-22844450330 10.1093/carcin/bgi073 (Pubitemid 41417910)
41. Blasiak J., Trzeciak A., Kowalik J., Curcumin damages DNA in human gastric mucosa cells and lymphocytes. Journal of Environmental Pathology, Toxicology and Oncology 1999 18 4 271 276 2-s2.0-0033501153 (Pubitemid 30140319)
42. Kelly M. R., Xu J., Alexander K. E., Loo G., Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutation Research-DNA Repair 2001 485 4 309 318 2-s2.0-0035837588 10.1016/S0921-8777(01)00066-0 (Pubitemid 32406285)
43. Cao J., Jia L., Zhou H., Liu Y., Zhong L., Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicological Sciences 2006 91 2 476 483 2-s2.0-33744805811 10.1093/toxsci/kfj153 (Pubitemid 43827300)
44. Urbina-Cano P., Bobadilla-Morales L., Ramírez-Herrera M. A., Corona-Rivera J. R., Mendoza-Magaña M. L., Troyo-Sanromán R., Corona-Rivera A., DNA damage in mouse lymphocytes exposed to curcumin and copper. Journal of Applied Genetics 2006 47 4 377 382 2-s2.0-33845455536 (Pubitemid 44893734)
45. Verschoyle R. D., Steward W. P., Gescher A. J., Putative cancer chemopreventive agents of dietary origin-how safe are they? Nutrition and Cancer 2007 59 2 152 162 2-s2.0-36849065338 (Pubitemid 350230732)
46. Burgos-Morón E., Calderón-Montaño J. M., Salvador J., Robles A., López-Lázaro M., The dark side of curcumin. International Journal of Cancer 2009 126 7 1771 1775 10.1002/ijc.24967
47. Sommerburg O., Keunen J. E. E., Bird A. C., van Kuijk F. J. G. M., Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. The British Journal of Ophthalmology 1998 82 8 907 910 2-s2.0-0031658490 (Pubitemid 28408149)
48. Eye Disease Case-Control Study Group, Antioxidant status and neovascular age-related macular degeneration. Archives of Ophthalmology 1993 111 1 104 109 10.1001/archopht.1993.01090010108035
49. Krinsky N. I., Landrum J. T., Bone R. A., Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annual Review of Nutrition 2003 23 171 201 2-s2.0-0042866149 10.1146/annurev.nutr.23.011702.073307 (Pubitemid 37059721)
50. Haegerstrom-Portnoy G., Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment? Journal of the Optical Society of America A 1988 5 12 2140 2144 2-s2.0-0024260326
51. Bian Q., Gao S., Zhou J., Qin J., Taylor A., Johnson E. J., Tang G., Sparrow J. R., Gierhart D., Shang F., Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radical Biology and Medicine 2012 53 6 1298 1307 10.1016/j.freeradbiomed.2012.06.024
52. Bian Q., Qin T., Ren Z., Wu D., Shang F., Lutein or zeaxanthin supplementation suppresses inflammatory responses in retinal pigment epithelial cells and macrophages. Advances in Experimental Medicine and Biology 2012 723 43 50 2-s2.0-84855958716 10.1007/978-1-4614-0631-0-7
53. Ma L., Yan S. F., Huang Y. M., Lu X. R., Qian F., Pang H. L., Xu X. R., Zou Z. Y., Dong P. C., Xiao X., Wang X., Sun T. T., Dou H. L., Lin X. M., Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophtalmology 2012 119 11 2290 2297 10.1016/j.ophtha.2012.06.014
54. Ma L., Dou H. L., Huang Y. M., Lu X. R., Xu X. R., Qian F., Zou Z. Y., Pang H. L., Dong P. C., Xiao X., Wang X., Sun T. T., Lin X. M., Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial. The American Journal of Ophthalmology 2012 154 4 625 634 10.1016/j.ajo.2012.04.014
55. Richer S. P., Stiles W., Graham-Hoffman K., Levin M., Ruskin D., Wrobel J., Park D., Thomas C., Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the zeaxanthin and visual function study (ZVF) FDA IND #78, 973. Optometry 2011 82 11 667.e6 680.e6 2-s2.0-82455171789 10.1016/j.optm.2011.08.008
56. Bone R. A., Landrum J. T., Guerra L. H., Ruiz C. A., Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentations of these carotenoids in humans. Journal of Nutrition 2003 133 4 992 998 (Pubitemid 36407115)
57. Makri O. E., Ferlemi A., Lamari F.N., Georgakopoulos C.D., Effect of Crocus sativus stigmas (saffron) extract on sodium selenite induced cataract formation. Acta Ophthalmologica 2012 90 article s249 10.1111/j.1755-3768.2012. S115.x
58. Falsini B., Piccardi M., Minnella A., Savastano C., Capoluongo E., Fadda A., Balestrazzi E., Maccarone R., Bisti S., Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Investigative Ophthalmology and Visual Science 2010 51 12 6118 6124 2-s2.0-77956979629 10.1167/iovs.09-4995
59. Alex A. F., Spitznas M., Tittel A. P., Kurts C., Eter N., Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro. Current Eye Research 2010 35 11 1021 1033 2-s2.0-77958515319 10.3109/02713683.2010.506970
60. Chan C., Huang J., Chiang H., Wu W., Lin H., Hong J., Hung C., Effects of (-)-epigallocatechin gallate on rpe cell migration and adhesion. Molecular Vision 2010 16 586 595 2-s2.0-77952309629
61. Lee S. M., Ko I., Kim S., Kim D. H., Kang B. N., Protective effect of catechin on apoptosis of the lens epithelium in rats with N-methyl-N- nitrosourea-induced cataracts. Korean Journal of Ophthalmology 2010 24 2 101 107 2-s2.0-77954691469 10.3341/kjo.2010.24.2.101
62. Maclennan K. M., Darlington C. L., Smith P. F., The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology 2002 67 3 235 257 2-s2.0-0036343060 10.1016/S0301-0082(02)00015-1 (Pubitemid 34880132)
63. Kim N. R., Kim J. H., Kim C. Y., Efect of Korean red ginseng supplementation on ocular blood flow in patients with glaucoma. Journal of Ginseng Research 2010 34 3 237 245 2-s2.0-79951803914 10.5142/jgr.2010.34.3.237
64. Cho J. Y., Yoo E. S., Baik K. U., Park M. H., Han B. H., In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-production and its modulation by known TNF- antagonists. Planta Medica 2001 67 3 213 218 2-s2.0-0035051648 10.1055/s-2001-12005 (Pubitemid 32304189)
65. Sen S., Chen S., Wu Y., Feng B., Lui E. K., Chakrabarti S., Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy. Phytotherapy Research 2012 27 2 290 298 2-s2.0-84860639302 10.1002/ptr.4719
66. Lee S. M., Sun J. M., Jeong J. H., Kim M. K., Wee W. R., Park J. H., Lee J. H., Analysis of the effective fraction of sun ginseng extract in selenite induced cataract rat model. Journal of the Korean Ophthalmological Society 2010 51 733 739
67. Osborne N. N., Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Progress in Brain Research 2008 173 339 352 2-s2.0-53049110307 10.1016/S0079-6123(08)01124-2
68. Li C., Wang L., Huang K., Zheng L., Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol. Investigative Ophthalmology and Visual Science 2012 53 6 3241 3249 10.1167/iovs.11-8406
69. Kwok T. L., Chiou R. Y. Y., Li G. C., Ming H. C., Wan T. T., Hsiang T. H., Yi L. Y., Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. Journal of Agricultural and Food Chemistry 2006 54 8 3126 3131 2-s2.0-33646526704 10.1021/jf053011q
70. Losa G. A., Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. European Journal of Clinical Investigation 2003 33 9 818 823 2-s2.0-0042834369 10.1046/j.1365-2362.2003.01219.x (Pubitemid 37082869)
71. Yar A. S., Menevse S., Dogan I., Alp E., Ergin V., Cumaoglu A., Aricioglu A., Ekmekci A., Menevse A., Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment. Journal of Medicinal Food 2012 15 4 391 398 2-s2.0-84859092595 10.1089/jmf.2011.0135
72. Kim Y. H., Kim Y. S., Roh G. S., Choi W. S., Cho G. J., Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmologica 2012 90 1 e31 e37 2-s2.0-84856517048 10.1111/j.1755-3768.2011.02243.x
73. Hua J., Guerin K. I., Chen J., Michán S., Stahl A., Krah N. M., Seaward M. R., Dennison R. J., Juan A. M., Hatton C. J., Sapieha P., Sinclair D. A., Smith L. E. H., Resveratrol inhibits pathologic retinal neovascularization in Vldlr-/- mice. Investigative Ophthalmology and Visual Science 2011 52 5 2809 2816 2-s2.0-79956045392 10.1167/iovs.10-6496
74. Osborne N. N., Casson R. J., Wood J. P. M., Chidlow G., Graham M., Melena J., Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Progress in Retinal and Eye Research 2004 23 1 91 147 2-s2.0-0842282082 10.1016/j.preteyeres.2003.12.001 (Pubitemid 38180539)
75. Zhu M., Cai F., Evidence of compromised circulation in the pathogenesis of optic nerve damage in chronic glaucomatous rabbit. Chinese Medical Journal 1993 106 12 922 927 2-s2.0-0027717457 (Pubitemid 24049146)
76. Wu Z. Z., Jiang J. Y., Yi Y. M., Xia M. T., Radix salviae miltiorrhizae in middle and late stage glaucoma. Chinese Medical Journal 1983 96 6 445 447 2-s2.0-0020592582
77. Zhang L., Dai S. Z., Nie X. D., Zhu L., Xing F., Wang L. Y., Effect of Salvia miltiorrhiza on retinopathy. Asian Pacific Journal of Tropical Medicine 2013 6 2 145 149 10.1016/S1995-7645(13)60011-5
78. Chen Y., Li X., Xing N., Cao X., Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 3 373 378 2-s2.0-39149099139 10.1007/s00417-007-0728-9
79. Stefek M., Karasu C., Eye lens in aging and diabetes: effect of quercetin. Rejuvenation Research 2011 14 5 525 534 2-s2.0-80055003490 10.1089/rej.2011.1170
80. Shetty A. K., Rashmi R., Rajan M. G. R., Sambaiah K., Salimath P. V., Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats. Nutrition Research 2004 24 5 373 381 2-s2.0-2942620341 10.1016/j.nutres.2003.11. 010 (Pubitemid 38739461)
81. Gacche R. N., Dhole N. A., Profile of aldose reductase inhibition, anti-cataract and free radical scavenging activity of selected medicinal plants: an attempt to standardize the botanicals for amelioration of diabetes complications. Food and Chemical Toxicology 2011 49 8 1806 1813 2-s2.0-79958748165 10.1016/j.fct.2011.04.032
82. Giaccio M., Crocetin from saffron: an active component of an ancient spice. Critical Reviews in Food Science and Nutrition 2004 44 3 155 172 2-s2.0-2942615338 10.1080/10408690490441433 (Pubitemid 38732378)
83. Soeda S., Ochiai T., Paopong L., Tanaka H., Shoyama Y., Shimeno H., Crocin suppresses tumor necrosis factor-induced cell death of neuronally differentiated PC-12 cells. Life Sciences 2001 69 24 2887 2898 2-s2.0-0035798068 10.1016/S0024-3205(01)01357-1 (Pubitemid 33030277)
84. Maccarone R., Di Marco S., Bisti S., Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Investigative Ophthalmology and Visual Science 2008 49 3 1254 1261 2-s2.0-41949111779 10.1167/iovs.07-0438
85. Ochiai T., Soeda S., Ohno S., Tanaka H., Shoyama Y., Shimeno H., Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis. Neurochemistry International 2004 44 5 321 330 2-s2.0-0345304238 10.1016/S0197-0186(03)00174-8 (Pubitemid 37485863)
86. Yamauchi M., Tsuruma K., Imai S., Nakanishi T., Umigai N., Shimazawa M., Hara H., Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. European Journal of Pharmacology 2011 650 1 110 119 2-s2.0-78649760813 10.1016/j.ejphar.2010.09.081
87. Lee S., Im K., Suh S., Jung J., Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Phytotherapy Research 2003 17 3 206 209 2-s2.0-0037354510 10.1002/ptr.1090 (Pubitemid 36406748)
88. Higdon J. V., Frei B., Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Critical Reviews in Food Science and Nutrition 2003 43 1 89 143 2-s2.0-0038121053 10.1080/10408690390826464 (Pubitemid 38552312)
89. Zhang B., Osborne N. N., Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate. Brain Research 2006 1124 1 176 187 2-s2.0-33751184363 10.1016/j.brainres.2006.09.067 (Pubitemid 44779557)
90. Siu A. W., Lau M. K., Cheng J. S., Chow C. K., Tam W. C., Li K. K., Lee D. K. L., To T. S. S., To C. H., Do C. W., Glutamate-induced retinal lipid and protein damage: the protective effects of catechin. Neuroscience Letters 2008 432 3 193 197 2-s2.0-39149127562 10.1016/j.neulet.2007.12.046
91. Zhang B., Rusciano D., Osborne N. N., Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Research 2008 1198 141 152 2-s2.0-43049163799 10.1016/j.brainres.2007.12.015
92. Costa B. L. D. S. A. D., Fawcett R., Li G., Safa R., Osborne N. N., Orally administered epigallocatechin gallate attenuates light-induced photoreceptor damage. Brain Research Bulletin 2008 76 4 412 423 2-s2.0-44149085394 10.1016/j.brainresbull.2008.01.022
93. Janssens D., Delaive E., Remacle J., Michiels C., Protection by bilobalide of the ischaemia-induced alterations of the mitochondrial respiratory activity. Fundamental and Clinical Pharmacology 2000 14 3 193 201 2-s2.0-0034046943 (Pubitemid 30413490)
94. Pierr S., Jamme I., Robert K., Gerbi A., Duran M. J., Sennoune S., Droy-Lefaix M. T., Nouvelot A., Maixent J. M., Ginkgo biloba extract (EGb 761) protects Na, K-ATPase isoenzymes during cerevral ischemia. Cell and Molecular Biology 2002 48 6 671 680
95. Sastre J., Lloret A., Borrás C., Pereda J., García-Sala D., Droy-Lefaix M. T., Pallardó F. V., Viña J., Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver. Cell and Molecular Biology 2002 48 6 685 692
96. Marcocci L., Maguire J. J., Droy-Lefaix M. T., Packer L., The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochemical and Biophysical Research Communications 1994 201 2 748 755 2-s2.0-0028338749 10.1006/bbrc.1994.1764 (Pubitemid 24206935)
97. Ma K., Xu L., Zhang H., Zhang S., Pu M., Jonas J. B., The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model. Acta Ophthalmologica 2010 88 5 553 557 2-s2.0-77954635960 10.1111/j.1755-3768.2008.01486.x
98. Qiu Q. H., Xie Z. G., Xu X., Liang S. X., Gao Y., EGB761 on retinal light injury in rats. Chinese Medical Journal 2012 125 13 2306 2309
99. Cybulska-Heinrich A. K., Mozaffarieh M., Flammer J., Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma. Molecular Vision 2012 18 390 402 2-s2.0-84857859399
100. Izzo A. A., Interactions between herbs and conventional drugs: overview of the clinical data. Medical Principles and Practice 2012 21 5 404 428 2-s2.0-84855604891 10.1159/000334488
101. Attele A. S., Wu J. A., Yuan C., Ginseng pharmacology: multiple constituents and multiple actions. Biochemical Pharmacology 1999 58 11 1685 1693 2-s2.0-0344549853 10.1016/S0006-2952(99)00212-9 (Pubitemid 29505408)
102. Kim Y. C., Kim S. R., Markelonis G. J., Oh T. H., Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. Journal of Neuroscience Research 1998 53 4 426 432 (Pubitemid 28363204)
103. Kim S., Ahn K., Oh T. H., Nah S., Rhim H., Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. Biochemical and Biophysical Research Communications 2002 296 2 247 254 2-s2.0-0036386954 10.1016/S0006-291X(02)00870-7
104. Xiong Y., Shen L., Liu K. J., Tso P., Xiong Y., Wang G., Woods S. C., Liu M., Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes 2010 59 10 2505 2512 2-s2.0-77957564323 10.2337/db10-0315
105. Lee W., Kao S. T., Liu I. M., Cheng J. T., Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clinical and Experimental Pharmacology and Physiology 2006 33 1-2 27 32 2-s2.0-33645083467 10.1111/j.1440-1681.2006.04319.x
106. Luo J. Z., Luo L., American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured β cells. Evidence-Based Complementary and Alternative Medicine 2006 3 3 365 372 2-s2.0-33748175972 10.1093/ecam/nel026 (Pubitemid 44310280)
107. Pignatelli P., Pulcinelli F. M., Celestini A., Lenti L., Ghiselli A., Gazzaniga P. P., Violi F., The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. The American Journal of Clinical Nutrition 2000 72 5 1150 1155 2-s2.0-0033753482
108. Russo P., Tedesco I., Russo M., Russo G. L., Venezia A., Cicala C., Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation. Nutrition, Metabolism and Cardiovascular Diseases 2001 11 1 25 29 2-s2.0-0035257986 (Pubitemid 33687791)
109. Slane P. R., Qureshi A. A., Folts J. D., Platelet inhibition in stenosed canine arteries by quercetin and rutin, polyphenolic flavonoids found in red wine. Clinical Research 1994 42 article A162
110. Corder R., Douthwaite J. A., Lees D. M., Khan N. Q., Viseu dos Santos A. C., Wood E. G., Carrier M. J., Endothelin-1 synthesis red wine. Nature 2001 414 6866 863 864 2-s2.0-0035924359 10.1038/414863a (Pubitemid 34024728)
111. Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A., Prabhu V. V., Allard J. S., Lopez-Lluch G., Lewis K., Pistell P. J., Poosala S., Becker K. G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K. W., Spencer R. G., Lakatta E. G., Le Couteur D., Shaw R. J., Navas P., Puigserver P., Ingram D. K., de Cabo R., Sinclair D. A., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006 444 7117 337 342 2-s2.0-33751072349 10.1038/nature05354 (Pubitemid 44764104)
112. Chanvitayapongs S., Draczynska-Lusiak B., Sun A. Y., Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. NeuroReport 1997 8 6 1499 1502 2-s2.0-0030917448 (Pubitemid 27242563)
113. Frankel E. N., Waterhouse A. L., Kinsella J. E., Inhibition of human LDL oxidation by resveratrol. The Lancet 1993 341 8852 1103 1104 2-s2.0-0027447124 (Pubitemid 23114451)
114. Shigematsu S., Ishida S., Hara M., Takahashi N., Yoshimatsu H., Sakata T., Korthuis R. J., Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radical Biology and Medicine 2003 34 7 810 817 2-s2.0-0037376409 10.1016/S0891-5849(02)01430-2 (Pubitemid 36316064)
115. Zhuang H., Kim Y., Koehler R. C., Doré S., Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Annals of the New York Academy of Sciences 2003 993 276 286 2-s2.0-0037713341 (Pubitemid 36808455)
116. Doganay S., Borazan M., Iraz M., Cigremis Y., The effect of resveratrol in experimental cataract model formed by sodium selenite. Current Eye Research 2006 31 2 147 153 2-s2.0-33644614553 10.1080/02713680500514685
117. Chen Y., Lin S., Ku H., Shiao M., Lin F., Chen J., Chen Y., Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-treated human aortic endothelial cells. Journal of Cellular Biochemistry 2001 82 3 512 521 2-s2.0-0034905011 10.1002/jcb.1176 (Pubitemid 32729414)
118. Wu Y., Hong C., Lin S., Wu P., Shiao M., Increase of vitamin e content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 3 481 486 2-s2.0-0031919197 (Pubitemid 28125644)
119. Sun X., Chan L. N., Gong X., Sucher N. J., N-methyl-D-aspartate receptor antagonist activity in traditional chinese stroke medicines. NeuroSignals 2003 12 1 31 38 2-s2.0-0038576216 10.1159/000068913 (Pubitemid 37490490)
120. Bhagwat S., Haytowitz D. B., Holden J. M., USDA Database for the Flavonoid Content of Selected Foods 2011 United States Department of Agriculture
121. Formica J. V., Regelson W., Review of the biology of quercetin and related bioflavonoids. Food and Chemical Toxicology 1995 33 12 1061 1080 2-s2.0-0029610477 10.1016/0278-6915(95)00077-1 (Pubitemid 26009773)
122. Stewart L. K., Soileau J. L., Ribnicky D., Wang Z. Q., Raskin I., Poulev A., Majewski M., Cefalu W. T., Gettys T. W., Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 2008 57 1 S39 S46 2-s2.0-44949251035 10.1016/j.metabol.2008.03.003 (Pubitemid 351814697)
123. Cao X., Liu M., Tuo J., Shen D., Chan C., The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Experimental Eye Research 2010 91 1 15 25 2-s2.0-77953356981 10.1016/j.exer.2010.03.016
124. Kook D., Wolf A. H., Yu A. L., Neubauer A. S., Priglinger S. G., Kampik A., Welge-Lüssen U. C., The protective effect of quercetin against oxidative stress in the human RPE in vitro. Investigative Ophthalmology and Visual Science 2008 49 4 1712 1720 2-s2.0-45549092748 10.1167/iovs.07-0477
125. 2+-induced oxidative stress in cultured retinal cells. Biochemical Pharmacology 2001 62 1 111 118 2-s2.0-0035400513 10.1016/S0006-2952(01)00621-9 (Pubitemid 32488982)
126. Zhuang P., Shen Y., Lin B. Q., Zhang W. Y., Chiou G. C., Effect of quercetin on formation of chrooidal neovascularization (CNV) in age-related macular degeneration (AMD). Eye Science 2011 26 1 23 29 10.3969/j.issn.1000- 4432.2011.01.006
127. Ishii Y., Kwong J. M. K., Caprioli J., Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Investigative Ophthalmology and Visual Science 2003 44 5 1982 1992 2-s2.0-0037408438 10.1167/iovs.02-0912 (Pubitemid 36520289)
128. Lamson D. W., Brignall M. S., Antioxidants and cancer III: quercetin. Alternative Medicine Review 2000 5 3 196 208 2-s2.0-0034202211 (Pubitemid 30419042)
129. Boots A. W., Haenen G. R. M. M., Bast A., Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology 2008 585 2-3 325 337 2-s2.0-43049176634 10.1016/j.ejphar.2008.03.008